TG Therapeutics, Inc. (TGTX) was a big mover last session, as the company saw its shares rise by over 21% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the near-flat price range of $12.910 to $15.130 in the past one-month time frame.
The company has seen three positive revisions in the past one month, while its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for this industry stock. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Sorrento Therapeutics currently carries a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Other well-placed stocks in the same industry include ICU Medical, Inc. (ICUI), OraSure Technologies, Inc. (OSUR) and Abaxis, Inc. (ABAX). All these stocks carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
TG THERAPEUTICS INC (TGTX): Free Stock Analysis Report
ICU MEDICAL INC (ICUI): Free Stock Analysis Report
ORASURE TECHNOLOGIES INC (OSUR): Free Stock Analysis Report
ABAXIS CP (ABAX): Free Stock Analysis Report
Zacks Investment Research